BlueRock
1 known investors
BlueRock Therapeutics is a clinical-stage cell therapy company developing treatments that aim to replace cells damaged or lost to disease, with programs targeting degenerative conditions such as Parkinson's disease. Its investigational cell therapies include bemdaneprocel and OpCT-001.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does BlueRock do?
- BlueRock Therapeutics is a clinical-stage cell therapy company developing treatments that aim to replace cells damaged or lost to disease, with programs targeting degenerative conditions such as Parkinson's disease. Its investigational cell therapies include bemdaneprocel and OpCT-001.
- Who are BlueRock's investors?
- BlueRock's investors include Versant Ventures.